25% off all training courses Offer ends May 29, 2026
View HIPAA Courses
25% off all training courses
View HIPAA Courses
Offer ends May 29, 2026

The HIPAA Journal is the leading provider of HIPAA training, news, regulatory updates, and independent compliance advice.

3 Medium Severity Vulnerabilities Identified in Philips MRI Solutions

Three medium severity vulnerabilities have been identified in Philips MRI products which, if exploited, could allow an unauthorized individual to run software, modify the device configuration, view and updates files, and export data, including protected health information (PHI), to an untrusted environment.

Aguilar found insufficient access controls which fail to restrict access by unauthorized individuals (CVE-2021-3083), the software assigns an owner who is outside the intended control sphere (CVE-2021-3085), and sensitive data is exposed to individuals who should not be provided with access (CVE-2021-3084). Each of the vulnerabilities has been assigned a CVSS V3 base score of 6.2 out of 10.

The vulnerabilities were identified by Secureworks Adversary Group consultant, Michael Aguilar, and affect Philips MRI 1.5T: Version 5.x.x, and MRI 3T: Version 5.x.x. Aguilar reported the flaws to Philips and a patch has been scheduled for release by October 2022. In the meantime, Philips recommends implementing mitigating measures to prevent the vulnerabilities from being exploited.

The mitigations include only operating the Philips MRI machines within authorized specifications, ensuring physical and logical controls are implemented. Only authorized personnel should be allowed to access the vicinity where the MRI machines are located, and all instructions for using the machines provided by Philips should be followed.

Get The FREE
HIPAA Compliance Checklist

Immediate Delivery of Checklist Link To Your Email Address

Please Enter Correct Email Address

Your Privacy Respected

HIPAA Journal Privacy Policy

Philips has not received any reports of the vulnerabilities being exploited, nor have there been any reports of incidents from the clinical use of the product in relation to the three vulnerabilities.

Author: Steve Alder is the editor-in-chief of The HIPAA Journal. Steve is responsible for editorial policy regarding the topics covered in The HIPAA Journal. He is a specialist on healthcare industry legal and regulatory affairs, and has 10 years of experience writing about HIPAA and other related legal topics. Steve has developed a deep understanding of regulatory issues surrounding the use of information technology in the healthcare industry and has written hundreds of articles on HIPAA-related topics. Steve shapes the editorial policy of The HIPAA Journal, ensuring its comprehensive coverage of critical topics. Steve Alder is considered an authority in the healthcare industry on HIPAA. The HIPAA Journal has evolved into the leading independent authority on HIPAA under Steve’s editorial leadership. Steve manages a team of writers and is responsible for the factual and legal accuracy of all content published on The HIPAA Journal. Steve holds a Bachelor’s of Science degree from the University of Liverpool. You can connect with Steve via LinkedIn or email via stevealder(at)hipaajournal.com

x

Is Your Organization HIPAA Compliant?

Find Out With Our Free HIPAA Compliance Checklist

Get Free Checklist